Old Web
English
Sign In
Acemap
>
authorDetail
>
Zhiwei Zhou
Zhiwei Zhou
Takeda Pharmaceutical Company
C1-inhibitor
Hereditary angioedema
Biology
Vascular endothelial growth factor
Duchenne muscular dystrophy
6
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
VEGFR-1/Flt-1 Inhibition Increases Angiogenesis and Improves Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy
2021
Molecular therapy. Methods & clinical development
Jennifer Bosco
Zhiwei Zhou
Sofie Gabriels
Mayank Verma
Nan Liu
Brian K. Miller
Sheng Gu
Dianna Lundberg
Yan Huang
Eilish Brown
Serene Josiah
Muthuraman Meiyappan
Matthew J. Traylor
Chen Nancy
Atsushi Asakura
Natalie De Jonge
Christophe Blanchetot
Hans de Haard
Heather S. Duffy
Dennis Keefe
Show All
Source
Cite
Save
Citations (3)
A robust multiplexed assay to quantify C1-inhibitor, C1q, and C4 proteins for in vitro diagnosis of hereditary angioedema from dried blood spot.
2021
Journal of Pharmaceutical and Biomedical Analysis
Yongquan Lai
Guodong Zhang
Neil Inhaber
Jonathan A. Bernstein
Michael Cwik
Zhiwei Zhou
Priya S. Chockalingam
Jiang Wu
Show All
Source
Cite
Save
Citations (1)
Parallel comparison of three methodologies for measuring functional C1-inhibitor in Hereditary angioedema patients.
2020
International Immunopharmacology
Archana Kapoor
Brijesh K. Garg
Zhiwei Zhou
Peng Lu
Priya S. Chockalingam
Show All
Source
Cite
Save
Citations (0)
A first of its kind quantitative functional C1-esterase inhibitor lateral flow assay for hereditary angioedema point-of-care diagnostic testing.
2020
International Immunopharmacology
Priya S. Chockalingam
Zhiwei Zhou
Brijesh K. Garg
Hans Boehringer
Roy Chung
Stephen Fait
Show All
Source
Cite
Save
Citations (0)
1